Affinage

DUOX2

Dual oxidase 2 · UniProt Q9NRD8

Length
1548 aa
Mass
175.4 kDa
Annotated
2026-04-28
13 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DUOX2 is a Ca²⁺-dependent, flavoprotein NADPH oxidase that generates hydrogen peroxide at the apical membrane of thyrocytes and intestinal epithelial cells, serving as the essential oxidant source for thyroperoxidase-catalyzed iodination of thyroglobulin during thyroid hormone biosynthesis and as a regulator of mucosal barrier function. The enzyme contains two EF-hand motifs conferring calcium dependence, plus FAD- and NADPH-binding domains that mediate electron transfer from NAD(P)H to molecular oxygen (PMID:10601291). Full enzymatic activity requires thyroid-specific maturation factors beyond thyroperoxidase and p22Phox, as the immature, incompletely glycosylated intracellular form produced in heterologous cells is catalytically inactive (PMID:11822874). Biallelic loss-of-function mutations in DUOX2 cause permanent congenital hypothyroidism due to defective H₂O₂ production and iodide organification, while monoallelic mutations produce transient hypothyroidism (PMID:12110737).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 1999 High

    Identification of DUOX2 as the principal thyroid H₂O₂-generating enzyme resolved the long-standing question of which oxidase supplies the oxidant for thyroid hormone synthesis, establishing its flavoprotein nature and Ca²⁺-dependent regulation via EF-hand motifs.

    Evidence Purification from pig thyroid plasma membrane, microsequencing, cDNA cloning, and domain analysis

    PMID:10601291

    Open questions at the time
    • Catalytic mechanism and stoichiometry of electron transfer not resolved
    • Whether DUOX2 produces superoxide or directly H₂O₂ not distinguished
  2. 2000 High

    Cloning of DUOX2 and DUOX1 as a paralog pair and demonstration of their apical thyrocyte colocalization with thyroperoxidase established the spatial framework for coupled H₂O₂ production and iodination at the thyroid apical surface.

    Evidence cDNA cloning, immunolocalization, Northern blot, and cAMP stimulation in dog thyroid

    PMID:10806195

    Open questions at the time
    • Relative contributions of DUOX1 versus DUOX2 to thyroidal H₂O₂ not determined
    • Mechanism of apical membrane targeting unknown
  3. 2001 Medium

    Confirmation that DUOX2 is an N-glycosylated apical membrane glycoprotein refined understanding of its post-translational processing as a prerequisite for surface expression.

    Evidence Western blot with antipeptide antibodies, immunohistochemistry, and tissue expression profiling

    PMID:11443211

    Open questions at the time
    • Identity of glycosylation sites and their functional necessity not mapped
    • Single-lab observation without independent replication
  4. 2002 High

    Demonstration that heterologously expressed DUOX2 is enzymatically inactive and that neither thyroperoxidase nor p22Phox rescues activity revealed a requirement for unidentified thyroid-specific maturation factor(s), later found to be the DUOXA proteins.

    Evidence Heterologous transfection in non-thyroid cells, co-expression with TPO and p22Phox, H₂O₂ generation assays

    PMID:11822874

    Open questions at the time
    • Identity of the maturation factor not determined at this point
    • ER-to-plasma-membrane trafficking mechanism unresolved
  5. 2002 High

    Discovery that biallelic DUOX2 mutations cause permanent congenital hypothyroidism—while monoallelic mutations cause transient forms—provided the definitive genetic proof that DUOX2-generated H₂O₂ is non-redundant for thyroid hormone synthesis in humans.

    Evidence Patient genomic DNA sequencing, genotype-phenotype correlation, perchlorate discharge test

    PMID:12110737

    Open questions at the time
    • Whether DUOX1 partially compensates in monoallelic cases not tested
    • Extrathyroidal consequences of DUOX2 loss not investigated
  6. 2004 Medium

    Characterization of the DUOX2 promoter as TATA-less and cAMP-unresponsive distinguished its transcriptional regulation from other thyroid-specific genes (thyroglobulin, NIS), indicating an independent regulatory logic.

    Evidence Gene structure determination, promoter-reporter transfection assays in thyroid cell lines, cAMP stimulation

    PMID:15062544

    Open questions at the time
    • Transcription factors driving thyroid-specific DUOX2 expression not identified
    • In vivo promoter activity not validated
  7. 2010 Medium

    Mapping of the bidirectional DUOX2–DUOXA2 promoter, with an Inr element driving DUOX2 and a TATA box driving DUOXA2, established co-regulation of the oxidase and its maturation factor as a coordinated transcriptional unit.

    Evidence RLM-RACE, bidirectional reporter assays in PCCl3 cells, EMSA, Sp1-site mutagenesis

    PMID:20060878

    Open questions at the time
    • Regulatory elements specific to intestinal DUOX2 expression not characterized
    • Whether bidirectional regulation ensures stoichiometric co-expression not tested
  8. 2024 Medium

    An IL-17–DUOX2 signaling axis was shown to control intestinal Candida albicans colonization, revealing DUOX2 as a key effector of mucosal antifungal defense downstream of candidalysin-triggered IL-17 signaling.

    Evidence Germ-free mouse colonization, IL-17 receptor knockout mice, colonoid culture with IL-17A, intestinal DUOX2-deficient mice (preprint)

    PMID:bio_10.1101_2024.08.16.608271

    Open questions at the time
    • Not yet peer-reviewed
    • Whether DUOX2-derived H₂O₂ is directly fungicidal or signals through downstream pathways not resolved
    • Relevance to human intestinal candidiasis not established

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis for DUOX2 activation by calcium, the identity of all maturation cofactors required for ER exit, and the precise mechanism by which DUOX2-derived ROS modulate intestinal epithelial barrier function remain unresolved.
  • No high-resolution structure of full-length DUOX2 in active versus inactive states
  • Mechanism of DUOXA2-dependent ER-to-plasma-membrane trafficking not fully elucidated
  • Relative contributions of DUOX2 versus other NOX family members to intestinal ROS not quantified

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0016491 oxidoreductase activity 2 GO:0140657 ATP-dependent activity 1
Localization
GO:0005886 plasma membrane 3
Pathway
R-HSA-1430728 Metabolism 3 R-HSA-168256 Immune System 1
Partners

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1999 DUOX2 (p138Tox) was purified from pig thyroid plasma membrane as a flavoprotein that constitutes the main component of the thyroid Ca2+-dependent NAD(P)H oxidase, generating H2O2 by transferring electrons from NAD(P)H to molecular oxygen; it contains two EF-hand motifs accounting for calcium-dependent activity and consensus FAD- and NADPH-binding sites. Protein purification from pig thyroid plasma membrane, microsequencing, cDNA cloning, domain analysis The Journal of biological chemistry High 10601291
2000 DUOX2 (ThOX2) and DUOX1 (ThOX1) encode new NADPH oxidase family members that accumulate at the apical membrane of thyrocytes co-localized with thyroperoxidase, and their mRNA expression in dog thyroid is regulated by cAMP pathway activation. cDNA cloning, Western blot, immunolocalization, Northern blot, cAMP stimulation assays The Journal of biological chemistry High 10806195
2002 DUOX2 (ThOX2) proteins are N-glycosylated (apparent MW 180-190 kDa; drops to 160 kDa upon deglycosylation), and their enzymatic H2O2-generating activity requires thyroid-specific processing: the immature intracellular form (present in non-thyroid transfected cells) is enzymatically inactive; co-expression with thyroperoxidase or p22Phox does not rescue activity, indicating that additional thyroid-specific components are required for full processing and activity. Western blot, deglycosylation assays, heterologous transfection in non-thyroid cell lines, co-expression with thyroperoxidase and p22Phox, H2O2 generation assays, PLB-XCGD cell complementation Experimental cell research High 11822874
2002 Biallelic (homozygous) inactivating mutations in DUOX2 (THOX2) result in complete disruption of thyroid hormone synthesis due to insufficient H2O2 production, causing severe permanent congenital hypothyroidism; monoallelic heterozygous truncating mutations cause partial H2O2 deficiency and milder transient congenital hypothyroidism. DNA sequencing of patient and family genomic DNA, genotype-phenotype correlation, perchlorate discharge test for iodide organification defect The New England journal of medicine High 12110737
2001 DUOX2 (LNOX2) protein localizes to the apical pole of thyrocytes and is a 164 kDa glycoprotein in which N-glycosylation accounts for at least 10-20 kDa of apparent molecular mass. Western blot with antipeptide antibodies, Northern blot across 23 human tissues, immunohistochemistry The Journal of clinical endocrinology and metabolism Medium 11443211
2004 The human THOX2 gene spans 75 kb, is composed of 34 exons, is arranged in head-to-head configuration with THOX1 separated by ~16 kb, and its promoter lacks a TATA box and is not positively controlled by cAMP (unlike thyroglobulin or NIS gene promoters), yet displays significant transcriptional activity in differentiated thyroid cell lines. Gene structure determination, promoter transfection assays in thyroid cell lines, cAMP stimulation Molecular and cellular endocrinology Medium 15062544
2010 THOX2 and DUOXA2 share a bidirectional promoter region with DUOXA2 containing a TATA box and THOX2 containing an Inr element; the THOX1-DUOXA1 promoter (but not THOX2-DUOXA2) contains functional Sp1 binding sites that drive bidirectional transcription. RLM-RACE transcription start site mapping, bidirectional reporter transfection assays in rat thyroid PCCl3 cells, gel shift/EMSA with Sp1, site-directed mutation of Sp1 sites Molecular and cellular endocrinology Medium 20060878
2024 An IL-17-DUOX2 axis controls gastrointestinal colonization by Candida albicans: IL-17 receptor signaling is required for upregulation of Duox2/Duoxa2 in intestinal epithelium in response to C. albicans (specifically requiring the yeast-hyphal transition and the hyphal toxin candidalysin); IL-17A addition to colonoids induces Duox2/Duoxa2 expression and H2O2 production; loss of intestinal DUOX2 function reduces fungal colonization at extended time points and increases hyphal proportion, with elevated IL-17A levels indicating cross-regulation. Germ-free mouse colonization with C. albicans, expression profiling, IL-17 receptor knockout mice, colonoid culture with IL-17A, intestinal DUOX2-deficient mice, fungal colonization quantification bioRxivpreprint Medium bio_10.1101_2024.08.16.608271
2025 Social disruption stress upregulates Duox2 and Duoxa2 expression in intestinal epithelial cells via β-adrenergic signaling; this upregulation is reversed by β-adrenergic receptor blockade (propranolol) but not by α2-adrenergic, CRH, or glucocorticoid inhibition; NADPH oxidase inhibition with apocynin mitigates stress-induced ROS production and colitis severity. Social disruption stress mouse model, pharmacological antagonists (propranolol, idazoxan, mifepristone, antalarmin), intestinal epithelial cell gene expression analysis, apocynin treatment, ROS/RNS measurement, colitis models (DSS and C. rodentium) bioRxivpreprint Medium bio_10.1101_2025.07.15.664961
2024 Duox2 is required for sentinel goblet cell-mediated secretory responses in the developing neonatal colon; microbiota-dependent development of functional sentinel goblet cells depends on the NADPH/Dual oxidase family member Duox2. In vivo and ex vivo analyses of pre- and post-weaning colonic mucus barrier in neonatal mice, Duox2-deficient mouse model bioRxivpreprint Low bio_10.1101_2024.07.03.601781

Source papers

Stage 0 corpus · 13 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. The Journal of biological chemistry 479 10806195
2002 Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. The New England journal of medicine 364 12110737
1999 Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. The Journal of biological chemistry 356 10601291
2005 Genetics of congenital hypothyroidism. Journal of medical genetics 263 15863666
2002 Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. Experimental cell research 147 11822874
2001 Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. The Journal of clinical endocrinology and metabolism 93 11443211
2004 Structural and functional characterization of the two human ThOX/Duox genes and their 5'-flanking regions. Molecular and cellular endocrinology 64 15062544
2006 Congenital hypothyroidism caused by new mutations in the thyroid oxidase 2 (THOX2) gene. Clinical endocrinology 45 17121535
2003 Thyroperoxidase gene mutations in congenital goitrous hypothyroidism with total and partial iodide organification defect. Thyroid : official journal of the American Thyroid Association 44 14751036
2011 Molecules important for thyroid hormone synthesis and action - known facts and future perspectives. Thyroid research 39 21835056
2010 Delimitation and functional characterization of the bidirectional THOX-DUOXA promoter regions in thyrocytes. Molecular and cellular endocrinology 24 20060878
2004 [Genetic aspects in congenital hypothyrodism]. Arquivos brasileiros de endocrinologia e metabologia 3 15611819
2020 Insilico study of genes involved in Congenital Hypothyroidism. JPMA. The Journal of the Pakistan Medical Association 1 32207419